FTC Approves Final Order Settling Charges that LabCorp’s Proposed Acquisition of Orchid Cellmark Inc. was Anticompetitive in Market for Paternity Testing Services

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Laboratory Corporation of America Holdings’ (LabCorp) proposed acquisition of rival firm Orchid Cellmark Inc. (Orchid) would have illegally reduced competition in the U.S. market for paternity testing services provided to government agencies.

View full post on Federal Trade Commission (FTC) – Text of Press Releases

, , , , , , , , , , , , , , ,

Comments are closed.

Get Adobe Flash player

RSS Site FeedRSS Site Feed

© 1992-2012 DC2NET™, Inc. All Rights Reserved